Bright Minds Biosciences, Inc. (DRUG.CX)
123.46
+0.68
(+0.55%)
CAD |
CNSX |
May 29, 16:00
Bright Minds Biosciences Enterprise Value : 901.79M for May 29, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Fennec Pharmaceuticals, Inc. | 418.78M |
| Microbix Biosystems, Inc. | 35.79M |
| Helix BioPharma Corp. | 124.82M |
| Sernova Biotherapeutics, Inc. | 65.65M |
| Covalon Technologies Ltd. | 45.14M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.46M |
| Total Expenses (Quarterly) | 10.46M |
| EPS Diluted (Quarterly) | -1.091 |
| Earnings Yield | -0.88% |